皮肤性病指南

订阅

MedSci主页 / 所有栏目 / 皮肤性病指南

祛斑美白类护肤品在黄褐斑中的应用指南

2022-02-09 中国中西医结合学会皮肤性病专业委员会色素病学组 中国皮肤性病学杂志

黄褐斑皮外与美容祛斑美白

黄褐斑发病机制复杂,疗效欠佳且易复发。随着对疾病的深入研究及祛斑美白类护肤品的迭代更新,为指导皮肤科医师科学、规范选用此类产品,该指南全面阐述了祛斑美白类护肤品在黄褐斑治疗中的作用机制及临床应用。

中文标题：

祛斑美白类护肤品在黄褐斑中的应用指南

发布机构：

中国中西医结合学会皮肤性病专业委员会色素病学组

发布日期：

2022-02-09

简要介绍：

黄褐斑发病机制复杂,疗效欠佳且易复发。随着对疾病的深入研究及祛斑美白类护肤品的迭代更新,为指导皮肤科医师科学、规范选用此类产品,该指南全面阐述了祛斑美白类护肤品在黄褐斑治疗中的作用机制及临床应用。 

相关资料下载：
[AttachmentFileName(sort=1, fileName=祛斑美白类护肤品在黄褐斑中的应用指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=aa58b1c002353eec, title=祛斑美白类护肤品在黄褐斑中的应用指南, enTitle=, guiderFrom=中国皮肤性病学杂志, authorId=0, author=, summary=黄褐斑发病机制复杂,疗效欠佳且易复发。随着对疾病的深入研究及祛斑美白类护肤品的迭代更新,为指导皮肤科医师科学、规范选用此类产品,该指南全面阐述了祛斑美白类护肤品在黄褐斑治疗中的作用机制及临床应用。, cover=https://img.medsci.cn/2022212/1644672860022_5579292.jpg, journalId=0, articlesId=null, associationId=2413, associationName=中国中西医结合学会皮肤性病专业委员会色素病学组, associationIntro=中国中西医结合学会皮肤性病专业委员会色素病学组, copyright=0, guiderPublishedTime=Wed Feb 09 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">黄褐斑发病机制复杂,疗效欠佳且易复发。随着对疾病的深入研究及祛斑美白类护肤品的迭代更新,为指导皮肤科医师科学、规范选用此类产品,该指南全面阐述了祛斑美白类护肤品在黄褐斑治疗中的作用机制及临床应用。&nbsp;</span></p>, tagList=[TagDto(tagId=37107, tagName=黄褐斑), TagDto(tagId=117873, tagName=皮外与美容), TagDto(tagId=122873, tagName=祛斑美白)], categoryList=[CategoryDto(categoryId=39, categoryName=皮肤性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9654, appHits=296, showAppHits=0, pcHits=1934, showPcHits=9357, likes=3, shares=38, comments=6, approvalStatus=1, publishedTime=Sun Feb 13 15:30:00 CST 2022, publishedTimeString=2022-02-09, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Feb 12 21:38:24 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 07:04:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=祛斑美白类护肤品在黄褐斑中的应用指南.pdf)])
祛斑美白类护肤品在黄褐斑中的应用指南.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2173961, encodeId=1ad721e3961c4, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b4aa8440342, createdName=ms6000000013039699, createdTime=Sun Dec 10 08:50:39 CST 2023, time=2023-12-10, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2113215, encodeId=f62e2113215ab, content=受用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75616409121, createdName=ms3000001946369408, createdTime=Mon Feb 06 09:21:38 CST 2023, time=2023-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238074, encodeId=499f12380e48e, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79561397839, createdName=zhangziyan1984, createdTime=Thu Aug 11 15:14:16 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205819, encodeId=8f4112058193f, content=临床超使用。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe306388685, createdName=ms7000001074540642, createdTime=Fri Mar 25 11:28:06 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193081, encodeId=3829119308190, content=已看完，非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sun Feb 13 21:19:52 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
    2023-12-10 ms6000000013039699 来自河北省

    感谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2173961, encodeId=1ad721e3961c4, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b4aa8440342, createdName=ms6000000013039699, createdTime=Sun Dec 10 08:50:39 CST 2023, time=2023-12-10, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2113215, encodeId=f62e2113215ab, content=受用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75616409121, createdName=ms3000001946369408, createdTime=Mon Feb 06 09:21:38 CST 2023, time=2023-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238074, encodeId=499f12380e48e, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79561397839, createdName=zhangziyan1984, createdTime=Thu Aug 11 15:14:16 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205819, encodeId=8f4112058193f, content=临床超使用。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe306388685, createdName=ms7000001074540642, createdTime=Fri Mar 25 11:28:06 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193081, encodeId=3829119308190, content=已看完，非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sun Feb 13 21:19:52 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
    2023-02-06 ms3000001946369408

    受用了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2173961, encodeId=1ad721e3961c4, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b4aa8440342, createdName=ms6000000013039699, createdTime=Sun Dec 10 08:50:39 CST 2023, time=2023-12-10, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2113215, encodeId=f62e2113215ab, content=受用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75616409121, createdName=ms3000001946369408, createdTime=Mon Feb 06 09:21:38 CST 2023, time=2023-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238074, encodeId=499f12380e48e, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79561397839, createdName=zhangziyan1984, createdTime=Thu Aug 11 15:14:16 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205819, encodeId=8f4112058193f, content=临床超使用。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe306388685, createdName=ms7000001074540642, createdTime=Fri Mar 25 11:28:06 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193081, encodeId=3829119308190, content=已看完，非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sun Feb 13 21:19:52 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
    2022-08-11 zhangziyan1984

    实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2173961, encodeId=1ad721e3961c4, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b4aa8440342, createdName=ms6000000013039699, createdTime=Sun Dec 10 08:50:39 CST 2023, time=2023-12-10, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2113215, encodeId=f62e2113215ab, content=受用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75616409121, createdName=ms3000001946369408, createdTime=Mon Feb 06 09:21:38 CST 2023, time=2023-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238074, encodeId=499f12380e48e, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79561397839, createdName=zhangziyan1984, createdTime=Thu Aug 11 15:14:16 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205819, encodeId=8f4112058193f, content=临床超使用。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe306388685, createdName=ms7000001074540642, createdTime=Fri Mar 25 11:28:06 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193081, encodeId=3829119308190, content=已看完，非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sun Feb 13 21:19:52 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
    2022-03-25 ms7000001074540642

    临床超使用。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2173961, encodeId=1ad721e3961c4, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b4aa8440342, createdName=ms6000000013039699, createdTime=Sun Dec 10 08:50:39 CST 2023, time=2023-12-10, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2113215, encodeId=f62e2113215ab, content=受用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75616409121, createdName=ms3000001946369408, createdTime=Mon Feb 06 09:21:38 CST 2023, time=2023-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238074, encodeId=499f12380e48e, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79561397839, createdName=zhangziyan1984, createdTime=Thu Aug 11 15:14:16 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205819, encodeId=8f4112058193f, content=临床超使用。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe306388685, createdName=ms7000001074540642, createdTime=Fri Mar 25 11:28:06 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193081, encodeId=3829119308190, content=已看完，非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sun Feb 13 21:19:52 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
    2022-02-13 ms3000000637975859

    已看完，非常好

    0

相关指南

中国黄褐斑诊疗专家共识（2021版）

中国中西医结合学会皮肤性病专业委员会 · 2021-02-26

黄褐斑光电治疗与修复专家共识

中华医学会皮肤性病学分会 · 2020-04-30

2015 中国黄褐斑治疗专家共识

暂未更新 · 2016-08-15